Dragos Mosneagu

Dragos Mosneagu, DPhil, has a diverse work experience spanning various roles and industries. Dragos started their career in 2014 with a research project at the University of Milan. In 2015, they joined the University of Oxford as a Research Assistant, where they identified and characterized molecules related to circadian rhythms. Dragos also completed an MSc research project during their time there. In 2018, Dragos co-founded the Oxford University Pharmacology Society and served as its President until 2020. Dragos then worked as a Consultant Intern at Alacrita Consulting in 2019. In 2020, they joined L.E.K. Consulting as a Life Sciences Specialist, specializing in the healthcare industry. Currently, they are employed at ADVANZ PHARMA, where they have held positions as a Senior Manager and Associate Director in Portfolio Strategy. Throughout their career, Dragos has focused their research on the relationship between diet, biological clock, and metabolic disorders.

Dragos Mosneagu, DPhil received their Bachelor's Degree in Pharmaceutical Biotechnology from Università degli Studi di Milano in 2014. Dragos then pursued further education at the University of Oxford, where they earned a Master's Degree in Pharmacology in 2015. Dragos continued their studies at the University of Oxford and completed their Doctor of Philosophy (Ph.D.) in Pharmacology in 2020. Additionally, they obtained several certifications, including Tableau and Alteryx, from Kubicle.